Showing results (141-150 of 262) with videos related to
Sort By:
Pageof 27
Journal of Experimental & Clinical Cancer Research : CR|July 18, 2023
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasionCorinna Kosnopfel, Simone Wendlinger, Heike Niessner, et al.Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.Nature Communications|September 1, 2021
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, et al.Frontiers in Cell and Developmental Biology|April 24, 2023
Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCsXiaoqing Xie, Pradeep Kumar Patnana, Daria Frank, et al.British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.Genes & Development|October 8, 2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsHua Jing, Julia Kase, Jan R Dörr, et al.Leukemia Research|December 24, 2025
Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemiaJulian Ronnacker, Marc-Andre Urbahn, Christian Reicherts, et al.Haematologica|October 15, 2020
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA studyChristopher R Bolen, Magdalena Klanova, Marek Trneny, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2005
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)Georg Lenz, Martin Dreyling, Eva Hoster, et al.Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.Pageof 27